Screening of human serum proteins for uranium binding

Area of Science:

• Biochemistry
• Toxicology
• Proteomics

Background:

• Approximately 20% of uranyl ions in serum bind to proteins, but most remain unidentified.
• Understanding these interactions is crucial for explaining uranium's biochemical toxicology and kinetics.
• Existing knowledge of uranium-protein interactions is limited, with only a few proteins like transferrin characterized.

Purpose of the Study:

• To identify novel uranium-binding proteins in human serum.
• To elucidate the biochemical mechanisms underlying uranium toxicity.
• To characterize the kinetics and binding stoichiometry of uranium with serum proteins.

Main Methods:

• Development of a sensitive in vitro procedure combining bidimensional chromatography with time-resolved fluorescence.
• Coupling chromatographic separation with advanced proteomic analysis for protein identification.
• Validation of identified uranium-binding proteins using purified proteins and inductively coupled plasma mass spectrometry (ICP-MS).

Main Results:

• Identification and validation of ten novel uranium-binding proteins in human serum fractions.
• Ceruloplasmin, hemopexin, and two complement proteins demonstrated high uranium-binding capacity (stoichiometry >1).
• Observed binding to non-metalloproteins suggests diverse uranyl ion coordination strategies.

Conclusions:

• The study identified key serum proteins that bind uranyl ions, expanding the known interactome of uranium.
• Findings indicate that uranyl ions can bind to a wide array of proteins using various binding sites and coordination methods.
• This research provides critical insights into the biochemical toxicology and kinetics of uranium exposure.